Axogen (AXGN) Asset Writedowns and Impairment (2016 - 2026)

Axogen's Asset Writedowns and Impairment history runs 11 years deep, the most recent figure standing at $68000.0 for Q2 2026.

• In Q2 2026, Asset Writedowns and Impairment fell 65.83% year-over-year to $68000.0; the TTM figure through Jun 2026 stood at -$38000.0 (down 107.48% YoY), while the FY2025 annual figure was $400000.0, down 38.46% from the prior year.
• Asset Writedowns and Impairment for Q2 2026 stood at $68000.0, up from -$120000.0 in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $789000.0 in Q3 2023, with the low at -$769000.0 in Q4 2022.
• The 5-year median for Asset Writedowns and Impairment is $193000.0 (2025), against an average of $193888.9.
• The sharpest annual moves came in 2022 and 2023: Asset Writedowns and Impairment plunged 265.73% in 2022, then jumped 105.2% in 2023.
• Axogen's Asset Writedowns and Impairment stood at -$769000.0 in 2022, then surged by 105.2% to $40000.0 in 2023, then grew by 15.0% to $46000.0 in 2024, then fell by 8.7% to $42000.0 in 2025, then jumped by 61.9% to $68000.0 in 2026.
• Business Quant data shows AXGN's Asset Writedowns and Impairment at $68000.0 in Q2 2026, -$120000.0 in Q1 2026, and $42000.0 in Q4 2025.